1921
Volume 85, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

We studied onchocerciasis transmission and impact on ocular morbidity in three health districts in North Region, Cameroon, where annual mass ivermectin treatment has been provided for 12–17 years. The studies, which took place from 2008 to 2010, consisted of skin snips for microfilariae (mf), palpation examinations for nodules, slit lamp examinations for mf in the eye, and vector dissections for larval infection rates. Adults had mf and nodule rates of 4.8% and 13.5%, respectively, and 5.5% had mf in the anterior chamber of the eye. Strong evidence of ongoing transmission was found in one health district, where despite 17 years of annual treatments, the annual transmission potential was 543 L3/person per year; additionally, children under 10 years of age had a 2.6% mf prevalence. Halting ivermectin treatments in North Cameroon now might risk recrudescence of transmission and ocular disease.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.2011.11-0333
2011-12-01
2019-06-16
Loading full text...

Full text loading...

/deliver/fulltext/14761645/85/6/1041.html?itemId=/content/journals/10.4269/ajtmh.2011.11-0333&mimeType=html&fmt=ahah

References

  1. Bottomley C, Isham V, Collins RC, Basáñez MG, , 2008. Rates of microfilarial production by Onchocerca volvulus are not cumulatively reduced by multiple ivermectin treatments. Parasitology 135: 15711581.[Crossref] [Google Scholar]
  2. Cupp EW, Cupp MS, , 2005. Short report: impact of ivermectin community-level treatments on elimination of adult Onchocerca volvulus when individuals receive multiple treatments per year. Am J Trop Med Hyg 73: 159161. [Google Scholar]
  3. Report WHO, , 2010. African Programme for Onchocerciasis Control—report of the sixth meeting of national task forces, October 2009. Wkly Epidemiol Rec 4: 2328. [Google Scholar]
  4. Katabarwa M, Eyamba A, Habomugisha P, Lakwo T, Ekobo S, Kamgno J, Kuete T, Ndyomugyenyi R, Onapa A, Salifou M, Ntep M, Richards FO, , 2008. After a decade of annual dose mass ivermectin treatment in Cameroon and Uganda, onchocerciasis transmission continues. Trop Med Int Health 13: 11961203.[Crossref] [Google Scholar]
  5. Boatin BA, Hougard JM, Alley ES, Akpoboua LK, Yaméogo L, Dembélé N, Sékétéli A, Dadzie KY, , 1998. The impact of Mectizan on the transmission of onchocerciasis. Ann Trop Med Parasitol 92: S46S60. [Google Scholar]
  6. Richards F, Hopkins D, Cupp E, , 2000. Programmatic goals and approaches to onchocerciasis. Lancet 355: 16631664.[Crossref] [Google Scholar]
  7. Winnen M, Plaisier AP, Alley ES, Nagelkerke NJ, van Oortmarssen G, Boatin BA, Habbema JD, , 2002. Can ivermectin mass treatments eliminate onchocerciasis in Africa? Bull World Health Organ 80: 384391. [Google Scholar]
  8. Borsboom GJ, Boatin BA, Nagelkerke NJ, Agoua H, Akpoboua KL, Alley EW, Bissan Y, Renz A, Yameogo L, Remme JH, Habbema JD, , 2003. Impact of ivermectin on onchocerciasis transmission: assessing the empirical evidence that repeated ivermectin mass treatments may lead to elimination/eradication in West Africa. Filaria J 2: 8.[Crossref] [Google Scholar]
  9. Ndyomugyenyi R, Tukesiga E, Büttner DW, Garms R, , 2004. The impact of ivermectin treatment alone and when in parallel with Simulium neavei elimination on onchocerciasis in Uganda. Trop Med Int Health 9: 882886.[Crossref] [Google Scholar]
  10. Diawara L, Traoré MO, Badji A, Bissan Y, Doumbia K, Goita SF, Konaté L, Mounkoro K, Sarr MD, Seck AF, Toé L, Tourée S, Remme JH, , 2009. Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal. PLoS Negl Trop Dis 3: e497.[Crossref] [Google Scholar]
  11. Anderson J, Fuglsang H, Marshall TF, Radolowicz A, Vaughan JP, , 1978. Studies on onchocerciasis in the United Cameroon Republic. IV. A four-year follow-up of six rain-forest and six savanna villages. The incidence of ocular lesions. Trans R Soc Trop Med Hyg 72: 513515.[Crossref] [Google Scholar]
  12. Chippaux JP, Boussinesq M, Fobi G, Lafleur C, Audugé A, Banos MT, Ngosso A, Prod'hon J, , 1999. Effect of repeated ivermectin treatments on ocular onchocerciasis: evaluation after six to eight doses. Ophthalmic Epidemiol 6: 229246.[Crossref] [Google Scholar]
  13. Renz A, Wenk P, Anderson J, Fuglsang H, , 1987. Studies on the dynamics of transmission of onchocerciasis in a Sudan-savanna area of North Cameroon V. What is a tolerable level of annual transmission potential? Ann Trop Med Parasitol 81: 263274.[Crossref] [Google Scholar]
  14. Renz AHJ, , 1985. Studies on the dynamics of transmission of onchocerciasis in a Sudan–Savanna of North Cameroon areas. Dissertation, University of Tubingen, Tubingen, Germany. [Google Scholar]
  15. Katabarwa MN, Habomugisha P, Richards FO, Jr, 2002. Implementing community-directed treatment with ivermectin for the control of onchocerciasis in Uganda (1997–2000): an evaluation. Ann Trop Med Parasitol 96: 6173.[Crossref] [Google Scholar]
  16. Salant P, Dilman DA, , 1994. How to Conduct Your Own Survey. New York, NY: John Wiley & Sons, Inc. [Google Scholar]
  17. Albiez EJ, Buttner DW, Duke BO, , 1988. Diagnosis and extirpation of nodules in human onchocerciasis. Trop Med Parasitol 39 (Suppl 4): 331346. [Google Scholar]
  18. Ngoumou P, Walsh JF, Mace JM, , 1994. A rapid mapping technique for the prevalence and distribution of onchocerciasis: a Cameroon case study. Ann Trop Med Parasitol 88: 463474.[Crossref] [Google Scholar]
  19. Katabarwa M, Onapa AW, Nakileza B, , 1999. Rapid epidemiological mapping of onchocerciasis in areas of Uganda where Simulium neavei sl. is the vector. East Afr Med J 76: 440446. [Google Scholar]
  20. Prost A, Prod'hon J, , 1978. Le diagnostique parasitologique de l'onchocercose. Revue critique des methods en usage. Medicine Tropicale 38: 519532. [Google Scholar]
  21. Schulz-Key H, , 1978. A simple technique to assess the total number of Onchocerca volvulus microfilariae in skin snips. Tropenmed Parasitol 29: 5154. [Google Scholar]
  22. Report of the World Health Organization, 1995. Onchocerciasis and its control. Report of a World Health Organization Expert Committee on Onchocerciasis Control. Technical Report Series 852. Geneva, Switzerland: World Health Organization. [Google Scholar]
  23. Report of the World Health Organization, 1991. Strategies for Ivermectin Distribution Through Primary Health Care System. Geneva, Switzerland: World Health Organization. [Google Scholar]
  24. Winthrop KL, Proaño R, Oliva O, Arana B, Mendoza C, Dominguez A, Amann J, Punkosdy G, Blanco C, Klein R, Sauerbrey M, Richards F, , 2006. The reliability of anterior segment lesions as indicators of onchocercal eye disease in Guatemala. Am J Trop Med Hyg 75: 10581062. [Google Scholar]
  25. Davies JB, , 1995. A rapid staining and clearing technique for detecting filarial larvae in alcohol-preserved vectors. Trans R Soc Trop Med Hyg 89: 280.[Crossref] [Google Scholar]
  26. Walsh JF, Davies JB, Le Berre R, Grams R, , 1978. Standardization of criteria for assessing the effect of Simulium control in onchocerciasis control programmes. Trans R Soc Trop Med Hyg 72: 675676.[Crossref] [Google Scholar]
  27. Gardon J, Boussinesq M, Kamgno J, Gardon-Wendel N, Demanga-Ngangue Duke BO, , 2002. Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomised controlled trial. Lancet 360: 203210.[Crossref] [Google Scholar]
  28. Boussinesq M, Prod'hon J, Chippaux JP, , 1997. Onchocerca volvulus: striking decrease in transmission in the Vina valley (Cameroon) after eight annual large scale ivermectin treatments. Trans R Soc Trop Med Hyg 91: 8286.[Crossref] [Google Scholar]
  29. Lindblade KA, Arana B, Zea-Flores G, Rizzo N, Porter CH, Dominguez A, Cruz-Ortiz N, Unnasch TR, Punkosdy GA, Richards J, Sauerbrey M, Castro J, Catú E, Oliva O, Richards FO, Jr, 2007. Elimination of Onchocercia volvulus transmission in the Santa Rosa focus of Guatemala. Am J Trop Med Hyg 77: 334341. [Google Scholar]
  30. Report of the World Healh Organization, (2001). Certification of elimination of human onchocerciasis: criteria and procedures. Criteria for Certification of Interruption of Transmission/Elimination of Human Onchocerciasis. Geneva, Switzerland: World Health Organization. [Google Scholar]
  31. Osei-Atweneboana MY, Eng JK, Boakye DA, Gyapong JO, Prichard RK, (2007). Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study. Lancet 369: 20212029.[Crossref] [Google Scholar]
  32. Ndyomugyenyi R, Lakwo T, Habomugisha P, Male B, , 2007. Progress towards the elimination of onchocerciasis as a public-health problem in Uganda: opportunities, challenges and the way forward. Ann Trop Med Parasitol 101: 323333.[Crossref] [Google Scholar]
  33. Gonzalez RJ, Cruz-Ortiz N, Rizzo N, Richards J, Zea-Flores G, Domínguez A, Sauerbrey M, Catú E, Oliva O, Richards FO, Lindblade KA, , 2009. Successful interruption of transmission of Onchocerca volvulus in the Escuintla-Guatemala focus, Guatemala. PLoS Negl Trop Dis 3: e404.[Crossref] [Google Scholar]
  34. Katabarwa MN, Eyamba A, Chouaibou M, Enyong P, Kuété T, Yaya S, Yougouda A, Baldiagaï J, Madi K, Andze GO, Richards F, , 2010. Does onchocerciasis transmission take place in hypoendemic areas? A study from the North Region of Cameroon. Trop Med Int Health 15: 645652.[Crossref] [Google Scholar]
  35. Seidenfaden R, Fischer A, Bonow I, Ekale D, Tanya V, Renz A, , 2001. Combined benefits of annual mass treatment with ivermectin and cattle zooprophylaxis on the severity of human onchocerciasis in northern Cameroon. Trop Med Int Health 9: 715725.[Crossref] [Google Scholar]
  36. Duke BO, Anderson J, Fuglsang H, , 1975. The Onchocerca volvulus transmission potentials and associated patterns of onchocerciasis at four Cameroon Sudan-savanna villages. Tropenmed Parasitol 26: 143154. [Google Scholar]
  37. Amazigo UV, Brieger WR, Katabarwa M, Akogun O, Ntep M, Boatin B, N'doyo J, Noma N, Seketeli A, , 2002. The challenges of community-directed treatment with ivermectin (CDTI) within the African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol 96: S75S92.[Crossref] [Google Scholar]
  38. Hopkins DR, Richards FO, Katabarwa M, , 2005. Whither onchocerciasis control in Africa. Am J Trop Med Hyg 72: 12. [Google Scholar]
  39. Rakers LJ, Emukah E, Onyenama J, Amah G, Ukairo N, Enyinnaya U, Miri E, Richards F, , 2009. Sustainability of ivermectin distribution programmes. Lance 374: 785786.[Crossref] [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2011.11-0333
Loading
/content/journals/10.4269/ajtmh.2011.11-0333
Loading

Data & Media loading...

  • Received : 25 May 2011
  • Accepted : 02 Aug 2011
  • Published online : 01 Dec 2011

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error